Literature DB >> 29240903

Declining Mortality Rates in HIV-Infected People Who Inject Drugs During a Seek-and-Treat Initiative in Vancouver, Canada, 1996-2014: A Prospective Cohort Study.

Kanna Hayashi1,2, Huiru Dong1,3, Thomas Kerr1,4, Sabina Dobrer1, Silvia Guillemi1, Rolando Barrios1, Julio S G Montaner1,4, Evan Wood1,4, M-J Milloy1,4.   

Abstract

We estimated rates and predictors of death among a community-recruited prospective cohort of 961 human immunodeficiency virus (HIV)-infected people who inject drugs in Vancouver, Canada, between 1996 and 2014. The results demonstrated significant declines in age-adjusted all-cause and HIV-related mortality rates since 2010, coincident with the scale-up of a community-wide "seek-and-treat" campaign.
© The Author(s) 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV; antiretroviral therapy; gender; injection drug use; mortality

Mesh：

Year:  2017        PMID： 29240903      PMCID： PMC5853785          DOI： 10.1093/infdis/jix459

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  10 in total

Review 1.  Self-report among injecting drug users: a review.

Authors:  S Darke
Journal:  Drug Alcohol Depend       Date:  1998-08-01       Impact factor: 4.492

2.  Opioid analgesic misuse in a community-based cohort of HIV-infected indigent adults.

Authors:  Maya Vijayaraghavan; Joanne Penko; David R Bangsberg; Christine Miaskowski; Margot B Kushel
Journal:  JAMA Intern Med       Date:  2013-02-11       Impact factor: 21.873

3.  Receipt of opioid analgesics by HIV-infected and uninfected patients.

Authors:  E Jennifer Edelman; Kirsha Gordon; William C Becker; Joseph L Goulet; Melissa Skanderson; Julie R Gaither; Jennifer Brennan Braden; Adam J Gordon; Robert D Kerns; Amy C Justice; David A Fiellin
Journal:  J Gen Intern Med       Date:  2012-08-16       Impact factor: 5.128

4.  Sex-Based Differences in Rates, Causes, and Predictors of Death Among Injection Drug Users in Vancouver, Canada.

Authors:  Kanna Hayashi; Huiru Dong; Brandon D L Marshall; Michael-John Milloy; Julio S G Montaner; Evan Wood; Thomas Kerr
Journal:  Am J Epidemiol       Date:  2016-02-09       Impact factor: 4.897

5.  Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.

Authors:  Julio S G Montaner; Viviane D Lima; Rolando Barrios; Benita Yip; Evan Wood; Thomas Kerr; Kate Shannon; P Richard Harrigan; Robert S Hogg; Patricia Daly; Perry Kendall
Journal:  Lancet       Date:  2010-07-16       Impact factor: 79.321

6.  Barriers to use of free antiretroviral therapy in injection drug users.

Authors:  S A Strathdee; A Palepu; P G Cornelisse; B Yip; M V O'Shaughnessy; J S Montaner; M T Schechter; R S Hogg
Journal:  JAMA       Date:  1998-08-12       Impact factor: 56.272

Review 7.  Mortality among people who inject drugs: a systematic review and meta-analysis.

Authors:  Bradley M Mathers; Louisa Degenhardt; Chiara Bucello; James Lemon; Lucas Wiessing; Mathew Hickman
Journal:  Bull World Health Organ       Date:  2013-02-01       Impact factor: 9.408

8.  Long-term Prescription of Opioids and/or Benzodiazepines and Mortality Among HIV-Infected and Uninfected Patients.

Authors:  Daniel F Weisberg; Kirsha S Gordon; Declan T Barry; William C Becker; Stephen Crystal; Eva J Edelman; Julie Gaither; Adam J Gordon; Joseph Goulet; Robert D Kerns; Brent A Moore; Janet Tate; Amy C Justice; David A Fiellin
Journal:  J Acquir Immune Defic Syndr       Date:  2015-06-01       Impact factor: 3.771

9.  Female gender predicts lower access and adherence to antiretroviral therapy in a setting of free healthcare.

Authors:  Christine Tapp; M-J Milloy; Thomas Kerr; Ruth Zhang; Silvia Guillemi; Robert S Hogg; Julio Montaner; Evan Wood
Journal:  BMC Infect Dis       Date:  2011-04-06       Impact factor: 3.090

10.  Improvements in HIV treatment outcomes among indigenous and non-indigenous people who use illicit drugs in a Canadian setting.

Authors:  M-J Milloy; Alexandra King; Thomas Kerr; Evan Adams; Hasina Samji; Silvia Guillemi; Evan Wood; Julio Montaner
Journal:  J Int AIDS Soc       Date:  2016-04-18       Impact factor: 5.396
  10 in total
  3 in total

1.  Scaling Up Hepatitis C Prevention and Treatment Interventions for Achieving Elimination in the United States: A Rural and Urban Comparison.

Authors:  Hannah Fraser; Claudia Vellozzi; Thomas J Hoerger; Jennifer L Evans; Alex H Kral; Jennifer Havens; April M Young; Jack Stone; Senad Handanagic; Susan Hariri; Carolina Barbosa; Matthew Hickman; Alyssa Leib; Natasha K Martin; Lina Nerlander; Henry F Raymond; Kimberly Page; Jon Zibbell; John W Ward; Peter Vickerman
Journal:  Am J Epidemiol       Date:  2019-08-01       Impact factor: 4.897

2.  Health programmes and services addressing the prevention and management of infectious diseases in people who inject drugs in Canada: a systematic integrative review.

Authors:  Katrina Bouzanis; Siddharth Joshi; Cynthia Lokker; Sureka Pavalagantharajah; Yun Qiu; Hargun Sidhu; Lawrence Mbuagbaw; Majdi Qutob; Alia Henedi; Mitchell A H Levine; Robin Lennox; Jean-Eric Tarride; Dale Kalina; Elizabeth Alvarez
Journal:  BMJ Open       Date:  2021-09-23       Impact factor: 3.006

3.  A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study.

Authors:  William C Miller; Irving F Hoffman; Brett S Hanscom; Tran V Ha; Kostyantyn Dumchev; Zubairi Djoerban; Scott M Rose; Carl A Latkin; David S Metzger; Kathryn E Lancaster; Vivian F Go; Sergii Dvoriak; Katie R Mollan; Sarah A Reifeis; Estelle M Piwowar-Manning; Paul Richardson; Michael G Hudgens; Erica L Hamilton; Jeremy Sugarman; Susan H Eshleman; Hepa Susami; Viet Anh Chu; Samsuridjal Djauzi; Tetiana Kiriazova; Duong D Bui; Steffanie A Strathdee; David N Burns
Journal:  Lancet       Date:  2018-09-01       Impact factor: 202.731
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.